Biomimix, Inc. (BMMX)
- Previous Close
0.0002 - Open
0.0002 - Bid --
- Ask --
- Day's Range
0.0002 - 0.0002 - 52 Week Range
0.0002 - 0.0002 - Volume
10,000 - Avg. Volume
9,500 - Market Cap (intraday)
-- - Beta (5Y Monthly) 0.83
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0050 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Biomimix, Inc. operates in the life science tools and services market covering genomics, proteomics, cell biology, analytical chemistry, bioprocess development, and bioinformatics in the United States. It develops and commercializes products based on processes and systems found in nature, known as biomimicry. The company's product portfolio includes Bonegrafix products, which are bioactive substances to produce graft attributes for bone replacement and filling defects or holes in bone, or stabilizing bone during the healing process; and ocean water based skin care products to supplement skin health. It also engages in the research and development of Medusa technology, an electro-chemical process that focuses on ballast water treatment, remote potable water treatment, and hydrogen production for use with portable renewable energy platforms. The company was formerly known as C'watre International, Inc. and changed its name to Biomimix, Inc. in April 2009. Biomimix, Inc. was founded in 1986 and is based in Ashburn, Virginia.
www.biomimix.net1
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Related News
Performance Overview: BMMX
Trailing total returns as of 4/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BMMX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BMMX
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-62.76%
Return on Equity (ttm)
--
Revenue (ttm)
34.76k
Net Income Avi to Common (ttm)
-182.45k
Diluted EPS (ttm)
-0.0050
Balance Sheet and Cash Flow
Total Cash (mrq)
893
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
65.95k
Company Insights: BMMX
BMMX does not have Company Insights